Conceived and designed the experiments: SY DL DY PF. Performed the experiments: SY. Analyzed the data: SY PF. Contributed reagents/materials/analysis tools: SY JP SJ SL SS DY. Wrote the paper: SY DY PF. Responsible for the Hyderabad research project: DL. Wrote the first draft of the paper: DY. PI for the Malawi research Programme: PF. Responsible for extracting DNA and genotyping all samples: SY. Did all the clinical, epidemiological, and biopsy work in Malawi: JP. Responsible for the clinical, epidemiological, and biopsy work in India: SJ and SS. Responsible for histopathology (and archiving) of Malawi biopsy material: SL.
Inadequate understanding of the transmission of
Genotyping assays based on variation in the copy number of short tandem repeat sequences were applied to biopsies collected in population-based epidemiological studies of leprosy in northern Malawi, and from members of multi-case households in Hyderabad, India. In the Malawi series, considerable genotypic variability was observed between patients, and also within patients, when isolates were collected at different times or from different tissues. Less within-patient variability was observed when isolates were collected from similar tissues at the same time. Less genotypic variability was noted amongst the closely related Indian patients than in the Malawi series.
Lineages of
Molecular typing has provided an important tool for studies of many pathogens. Such methods could be particularly useful in studies of leprosy, given the many outstanding questions about the pathogenesis and epidemiology of this disease. The approach is particularly difficult with leprosy, however, because of the genetic homogeneity of
Implementation of standardised multidrug regimens in the 1980s and 1990s has had a major impact on global leprosy prevalence, through shortening the duration of treatment. While it was reasoned that effective treatment of individual patients would reduce the spread of
Publication of the genome sequence of an
In contrast to the extreme conservation uncovered by SNP analysis, several researchers have reported a highly dynamic pattern of variation in copy number of short tandem repeat sequences in the
The aim of the present study was to assess whether differences in copy number of short tandem repeats provides information that is informative about the transmission of
The Malawi (Karonga) series included 43 biopsies which had been collected for diagnostic purposes from 17 leprosy patients at the same or different times. The patients were identified from records of the Karonga Prevention Study
The Indian (Hyderabad) series included 20 biopsies from 20 patients from eight families with more than one patient. All these patients were diagnosed at the outpatients clinic of the Blue Peter Research centre (BPRC), Hyderabad, India. All biopsies had been taken by 6 mm punch for diagnostic purposes, fixed in 10% buffered formal saline, embedded in paraffin and processed for histopathology
Ten sections of 5 µm thickness were collected in a separate vial for each sample. A separate blade was used to cut each block in order to avoid cross contamination. The sections were deparaffinised prior to extraction. 100 µl of extraction buffer (90 µl of 0.5 M EDTA pH 8.0, 0.5% SDS+10 µl Proteinase K–QIAGEN) was added to each sample, mixed and incubated with constant agitation at 56°C overnight. Each sample was centrifuged at 223×g for 5 min and 100 µl of the supernatant then transferred into a tube containing 0.5 ml PB buffer (QIAGEN PCR purification kit) and thereafter DNA extraction was done according to the manufacturer's instructions
A total of seven repeat loci were examined. These were identified by analysis of the
| Locus | Genome location | Repeat size | PCR primers | Amplicon size | Repeat sequence | Translated sequence |
| ML2172 | 2583816–2583839 | 3 bp | F: |
151 bp | AGT | (intergenic) |
| R: |
||||||
| ML2334 | 2785432–2785494 | 3 bp | F: |
131 bp | TTC | (intergenic) |
| R: |
||||||
| ML1505 | 1816857–1816892 | 6 bp | F: |
173 bp | GCACCT | Pro-Ala repeat |
| R: |
||||||
| ML1182 | 1381661–1381723 | 12 bp | F: |
157 bp |
|
Glu-Val-Val-Glu repeat |
| R: |
||||||
| ML0058 | 73077–73139 | 21 bp | F: |
186 bp |
|
(pseudogene) |
| R: |
||||||
| ML2469 | 2945487–2945555 | 23 bp | F: |
188 bp |
|
(intergenic) |
| R: |
||||||
| ML2418 | 2893248–2893761 | 25 bp | F: |
189 bp |
|
(pseudogene) |
| R: |
PCR was performed on a Hybaid Express thermal cycler in a final volume of 25 µl using the ‘Hot-Start’ Excite Core Kit (BioGene) according to the manufacturer's instructions. After an initial denaturation step (10 min at 95°C), 45 cycles of amplification were performed as follows: denaturation at 95°C for 15s, annealing at 58°C for 40s, and extension at 72°C for 30s. A final extension was performed at 72°C for 2 min. PCR products were initially screened by electrophoresis in 2% (w/v) agarose gels. For sequencing, products were separated on 2% (w/v) low melting point agarose (Invitrogen) and bands were excised with a sterile scalpel blade and purified using a GeneClean DNA isolation kit (Q-BIO gene). Cycle sequencing was performed on a PE 2700 system with ABI Big Dye 3.1 Terminator Ready Reaction Kit (Applied Biosystems) according to the manufacturer's protocol, with subsequent analysis on an ABI 3730 Genetic Analyzer.
Based on inspection of the genome sequence of
| Number of Copies | Short tandem repeat locus | ||||||
| ML2172 | ML2334 | ML1505 | ML1182 | ML0058 | ML2469 | ML2418 | |
|
|
8 | ||||||
|
|
29 | 43 | 43 | ||||
|
|
6 | ||||||
|
|
4 | ||||||
|
|
39 | ||||||
|
|
32 | ||||||
|
|
1 | 9 | |||||
|
|
18 | ||||||
|
|
19 | 4 | |||||
|
|
4 | 8 | |||||
|
|
1 | ||||||
|
|
11 | ||||||
|
|
1 | ||||||
|
|
2 | ||||||
|
|
4 | ||||||
|
|
11 | ||||||
|
|
2 | ||||||
|
|
8 copies | 10 copies | 7 copies | 5 copies | 2 copies | 2 copies | 2 copies |
|
|
9 copies | 21 copies | 7 copies | 5 copies | 3 copies | 3 copies | 5 copies |
Numbers in the table give the number of biopsies with each particular number of copies of each of seven tandem repeat loci. The “reference” strain was derived from a patient in USA; the “sequence” strain was derived from a South Indian patient (Cole et al, 2001).
Polymorphism was more extensive in the case of the shorter repeat elements. The two longer repeats, ML2469/70 (23 bp) and ML2418 (25 bp), were uniformly present in two copies in all of the Malawi samples. This differs from the copy numbers in the sequenced isolate (3 and 5 copies respectively) but is identical to a recent sample of armadillo derived
To assess the utility of genotypic analysis for mapping of transmission, we first assessed whether repeat copy number could vary between samples from a single individual, by analysis of Malawi biopsies taken at a single timepoint from different anatomical sites or tissues, and biopsies taken from the same individual at different times.
For seven patients, we tested paired skin biopsies taken at the same time from different skin lesions (
| Patient number | Age (yrs) | Site/classification | Short tandem repeat loci | ||||
| ML2172 | ML2334 | ML1505 | ML1182 | ML0058 | |||
| 2 | 60 | Skin/BT | 9 | 10 | 6 | 4 | 3 |
| Skin/BT | 9 | 10 | 6 | 4 | 3 | ||
| 3 | 44 | Skin/BT | 8 | 12 | 6 | 5 | 2 |
| Skin/BT | 8 | 12 | 6 | 5 | 2 | ||
| 4 | 55 | Skin/LL | 9 | 16 | 6 | 5 | 1 |
| Skin/LL | 9 | 16 | 6 | 5 | 1 | ||
| 7 | 46 | Skin/TT | 9 | 9 | 6 | 5 | 2 |
| Skin/TT | 9 | 9 | 6 | 5 | 2 | ||
| 10 | 38 | Skin/BL | 8 | 14 | 7 | 5 | 2 |
| Skin/BL | 8 | 14 | 7 | 5 | 2 | ||
| 16 | 35 | Skin/BL | 9 | 9 | 6 | 5 | 2 |
| Skin/BL | 9 | 9 | 6 |
|
2 | ||
| 17 | 37 | Skin/BL | 9 | 10 | 6 | 4 | 1 |
| Skin/BL | 11 | 17 | 6 | 5 | 3 | ||
Histopathological classifications in column 3.
Biopsies taken from skin and nerve lesions at a single timepoint were analysed from seven patients (
| Patient number | Age (yrs) | Site/classification | Short tandem repeat loci | ||||
| ML2172 | ML2334 | ML1505 | ML1182 | ML0058 | |||
| 1 | 52 | Skin/BT | 9 | 10 | 7 | 5 | 2 |
| Nerve/BT | 9 | 16 | 6 | 5 | 2 | ||
| 5 | 63 | Skin/BT | 8 | 12 | 7 | 5 | 3 |
| Nerve/BL | 8 | 12 | 6 | 5 | 3 | ||
| 6 | 35 | Skin/ BT | 9 | 15 | 6 | 5 | 2 |
| Nerve/BL | 10 | 15 | 6 | 5 | 2 | ||
| 9 | 31 | Skin/IND | 8 | 16 | 6 | 5 | 2 |
| Nerve/BL | 8 | 16 | 6 | 5 | 1 | ||
| 11 | 37 | Skin/BT | 9 | 16 | 6 | 4 | 2 |
| Nerve/BT | 10 | 16 | 6 | 5 | 2 | ||
| Nerve/BT | 10 | 16 | 6 | 5 | 2 | ||
| 12 | 23 | Skin/BT | 9 | 12 | 6 | 5 | 1 |
| Nerve/BT | 7 | 10 | 6 | 5 | 2 | ||
| 13 | 52 | Skin/BT | 8 | 13 | 7 | 5 | 1 |
| Nerve/BL | 8 | 10 | 6 | 5 | 2 | ||
Histopathological classifications in column 3.
Biopsies taken at multiple timepoints were analysed for four Malawian patients for whom clinical analysis had been repeated as a result of relapse or reactivation episodes (
| Patient number | Date (Age in yrs) | Site/classification | Short tandem repeat loci | ||||
| ML2172 | ML2334 | ML1505 | ML1182 | ML0058 | |||
| 4 | 05/90 (55) | Skin/LL | 9 | 16 | 6 | 5 | 1 |
| 11/94 (59) | Skin/BT | 9 | 12 | 7 | 5 | 2 | |
| 5 | 01/87 (63) | Nerve/BL | 8 | 12 | 6 | 5 | 3 |
| 01/88 (64) | Nerve/BT | 8 | 12 | 6 | 5 | 2 | |
| 8 | 07/89 (53) | Skin/BL | 8 | 15 | 6 | 5 | 2 |
| 10/89 (53) | Skin/BL | 10 | 15 | 6 | 5 | 2 | |
| 10/90 (54) | Skin/ |
8 | 12 | 6 | 5 | 2 | |
| 07/94 (58) | Skin/BT | 9 | 12 | 6 | 5 | 2 | |
| 15 | 07/90 (45) | Skin/IND | 9 | 16 | 6 | 5 | 2 |
| 08/93 (48) | Skin/IND | 8 | 12 | 6 | 5 | 3 | |
The initial biopsies of patients 4 and 5 are included in
Copy numbers at three of the repeat loci were analysed for a panel of skin biopsies taken from the Indian patients from eight multicase families (
| Household | Relationship between patients | Age | Class | Year | Short tandem repeat loci | ||
| ML2172 | ML2334 | ML0058 | |||||
|
|
Father | 38 | LL | 2001 | 8 | 14 | nd |
| daughter | 14 | BL | 2001 | 8 | 14 | nd | |
|
|
Brother | 10 | BT | 2000 | 8 | 12 | 2 |
| sister | 12 | BT( |
2000 | 8 | 12 | 2 | |
|
|
Mother | 28 | LL( |
2004 | 8 | 17 | 2 |
| Brother * | 17 | LL | 2000 | 8 | 17 | 2 | |
| son | 14 | BL | 2003 | 8 | 17 | 2 | |
|
|
Mother | 61 | BL( |
2003 | 9 | 16 | 2 |
| son | 25 | LL( |
2004 | 9 | 13 | 2 | |
| daughter-in-law | 20 | BT( |
2004 | 9 | 13 | 2 | |
| grandson | 6 | BL( |
2004 | 9 | 13 | 2 | |
| mother of d-i-law * | 48 | BL | 2004 | 8 | 14 | 1 | |
|
|
Husband | 25 | BT( |
2003 | 8 | 13 | 2 |
| Wife | 22 | BT | 2004 | 8 | 13 | 2 | |
|
|
brother-in-law | 31 | LL( |
2000 | 8 | 13 | 2 |
| brother-in-law ** | 26 | LL( |
2001 | 8 | 13 | 2 | |
|
|
Husband | 25 | LL( |
2003 | 10 | 10 | 2 |
| Wife | 20 | BT( |
2004 | 12 | 10 | 2 | |
|
|
Brother | 21 | LL( |
2002 | 8 | 16 | 3 |
| Brother | 20 | BT | 2004 | 8 | 16 | 3 | |
All members of each family group lived in the same household residence except for individuals marked *, who lived in separate residences nearby, and individual marked ** who lived in another household, in another village. Abbreviations:
Our findings in the Malawi patients are consistent with previous publications demonstrating extensive polymorphism in the copy number of short tandem repeat sequences of
While we cannot exclude the possibility that changes in repeat copy number have potentially selectable phenotypic consequences, inspection of the predicted changes does not indicate any obvious biological significance. Three of the repeats are located outside of coding regions. The 6bp ML1505 locus introduces a variable number of Pro-Ala repeats within a conserved hypothetical protein; the 12bp ML1182 locus encodes a Glu-Val-Val-Glu repeat in a member of the PPE protein family; the ML0058 21bp repeat, ML2469 23bp repeat and the ML2418 25bp repeat are located in pseudogenes.
Analysis of multiple Malawi biopsies collected at the same time reproduced our previous finding among Indian patients
The potential occurrence of genotypic variation within individual patients points to a need for considerable caution in any application of this type of analysis to tracking of transmission between individuals. On the other hand, when we analysed repeat copy numbers at three loci for individuals with a high probability of sharing a transmission link as a result of living in the same household, in Hyderabad, India, we observed a strong concordance in bacterial genotype. This is consistent with our earlier observation in this same population
The homogeneity in genotypes between individuals within households in the Hyderabad series contrasts with the differences observed between individuals in Malawi, and also with the differences observed within individuals over time and between tissues in the Malawi series. We offer three comments on these patterns. First, as only three loci were examined in the Hyderabad series, versus five in the Malawi patients, our ability to detect differences was lower for the Indian than for the Malawian series. This may have increased the apparent homogeneity of the Hyderabad household sets. Second, the Indian series included more individuals towards the lepromatous pole than did the Malawi series. Perhaps the relatively unrestrained growth of
Taken together, our findings suggest that genotyping of
We thank the field and clinic staff in Malawi and India who were responsible for patient diagnosis and care, the Malawi National Health Sciences Research Committee for supporting the work in Karonga.
The authors have declared that no competing interests exist.
The Karonga and Hyderabad programmes were funded largely by the British Leprosy Relief Association (LEPRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.